Newsletter
AMERICAN ASSOCIATION OF PHY SICISTS IN MEDICIN E VOLUME 32 NO. 4
JULY/AUGUST 2007
AAPM President’s Column
Mary K. Martel UT MD Anderson Cancer Center
P
ractically all the information you need regarding the annual meeting is available online at aapm. org/meetings/07AM/, but I would like to highlight a couple of the meeting activities in this column. President’s Symposium “Biomarker” can mean different things to different scientists, dependent on the medical or biological science specialty they are in. For those of us in the cancer therapy field, imaging as a biomarker has been emerging as an important area of research. In particular, measurement of treatment response with imaging could aim towards use of imaging as a predictive factor pre-treatment (or during treatment), eventually aiding in the choice of a targeted therapy for patients. The previous sentence contains a lot of complex information, and indicates loads of research and development work for decades to come! Validation
of imaging as a biomarker(s) is the first step towards use of imaging in a reliable way in drug development and oncology trials, providing a robust clinical trial infrastructure. The President’s Symposium this year will explore several facets of this subject with “Imaging as a Biomarker for Therapy Response: Challenges, Opportunities and Initiatives”. The following questions (and more) will be addressed: How can imaging become ‘more’ quantitative? What role will the medical physicist play in future developments and use of imaging as a biomarker? What funding opportunities for research and development exist, particularly at the national level? Our invited speakers are LH Schwartz, MD, Vice Chair for Technology Development and Director of MRI at Memorial Sloan-Kettering, Barbara Mittleman, MD, director of the NIH’s Public-Private Partnership Program, Biomarker Consortium, Michael Vannier, MD, Professor of Radiology at the University of Chicago, and Gary Becker, MD, Professor of Radiology at the University of Arizona and Chairman of the Board of RSNA. Thanks to Dr. Larry Clarke of the NIH for his guidance in the development of this symposium. There are also two associated symposiums later during the meeting week: Molecular Imaging: Biomarkers on Tuesday afternoon and Imaging for Therapy Assessment on Wednesday afternoon and of course a number of related talks and sessions throughout the meeting.
Meet the AAPM Leadership There will be several venues during the annual meeting that provide opportunities to directly interact with the AAPM leadership. On Tuesday afternoon, there will be a New Member Symposium combined with “Meet the Experts.” A Town Hall meeting, followed by the Annual Business Meeting is scheduled for Wednesday afternoon. And for those of you still in Minneapolis on Thursday, the AAPM Board meets that day. The leadership wants to hear from you: what should the AAPM be working on? How can the organization better serve you? Each of these events gives the membership a chance to ask those burning questions of members of the Board and Council Chairs; don’t pass it up!
TABLE OF CONTENTS Chairman of the Board Column p. 2 President Elect’s Column p. 3 Executive Director’s Column p. 5 Editor’s Column p. 7 Education Council Report p. 8 Professional Council Report p. 10 CAMPEP News p. 13 Health Policy/Economics p. 14 Leg. & Reg. Affairs p. 17 Chapter News p. 18 Copyright Issues p. 20 ACR Accreditation FAQS p. 25